| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |